Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025
P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program